Precision Biopsy: Precision Biopsy asks FDA to OK new ClariCore trial

Precision Biopsy said today it submitted an application to the FDA seeking a go-ahead to expand the trial of its ClariCore prostate biopsy system into a new Transrectal Ultrasound and MR/Fusion arm. The ClariCore system is designed for the spectral analysis of tissue samples during biopsies to "rapidly classify" tissue as normal or suspicious using an [...]The post Precision Biopsy asks FDA to OK new ClariCore trial appeared first on MassDevice.